Back to Journals » Journal of Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma
ISSN: 2253-5969

Editor-in-Chief: Dr Ahmed Kaseb
The Journal of Hepatocellular Carcinoma is an international, peer-reviewed, open access journal.
The journal welcomes original research manuscripts, reviews, clinical trial reports, expert opinions and commentaries relating to all aspects of HCC, spanning from basic laboratory research through to clinical and translational research.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Journal Impact Factor: 4.655
Indexed online:
- PubMed and PubMed Central (J Hepatocell Carcinoma)
- Science Citation Index Expanded (also known as SciSearch®)
- Journal Citation Reports/Science Edition
- Current Contents®/Life Sciences
- Embase, from 2018 (Correct as at September 10, 2018)
- Directory of Open Access Journals (DOAJ)
- OAIster: The Open Access Initiative
Articles:
- View all (149)
- Volume 8, 2021 (22)
- Volume 7, 2020 (37)
- Volume 6, 2019 (16)
- Volume 5, 2018 (14)
- Volume 4, 2017 (16)
- Volume 3, 2016 (10)
- Volume 2, 2015 (17)
- Volume 1 , 2014 (17)
Latest articles:
- 5 records -
ARHGAP20 Expression Inhibited HCC Progression by Regulating the PI3K-AKT Signaling Pathway
Liu G, Li J, Zhang CY, Huang DY, Xu JW
Journal of Hepatocellular Carcinoma 2021, 8:271-284
Published Date: 21 April 2021
Ultrasound-Guided Percutaneous Ethanol-Paclitaxel Combined Therapy for Rabbit VX2 Liver Tumors
Chen L, Liu ZX, Bi QC, Zhao J, Liang QR, Tang Q
Journal of Hepatocellular Carcinoma 2021, 8:263-270
Published Date: 20 April 2021
Selecting an Optimal Staging System for Intermediate-Stage Hepatocellular Carcinoma: Comparison of 9 Currently Used Prognostic Models
Zhang YF, Shi M, Lu LH, Wang L, Guo RP
Journal of Hepatocellular Carcinoma 2021, 8:253-261
Published Date: 19 April 2021
A Comparison of Lenvatinib versus Sorafenib in the First-Line Treatment of Unresectable Hepatocellular Carcinoma: Selection Criteria to Guide Physician’s Choice in a New Therapeutic Scenario
Dipasquale A, Marinello A, Santoro A
Journal of Hepatocellular Carcinoma 2021, 8:241-251
Published Date: 15 April 2021
NAFLD-Associated HCC: Progress and Opportunities
Geh D, Anstee QM, Reeves HL
Journal of Hepatocellular Carcinoma 2021, 8:223-239
Published Date: 8 April 2021